Reports On Company: Model Portfolio
| Best Specialty Chemicals Stocks To Buy Now: Motilal Oswal Research Report | |
| Company: | Model Portfolio, Specialty Chemicals |
| Brokerage: | Motilal Oswal |
| Date of report: | June 1, 2021 |
| Type of Report: | Model Portfolio Sector Report |
| Recommendation: | Buy |
| Upside Potential: | 100% |
| Summary: | Specialty Chemicals: Genie is out! |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | |
Reports On Company: Model Portfolio
| NIFTY target raised to 17400 + Top 16 Small Cap, Mid Cap and Large Cap Stocks To Buy | |
| Company: | Model Portfolio |
| Brokerage: | Axis Securities |
| Date of report: | July 1, 2021 |
| Type of Report: | Model Portfolio |
| Recommendation: | Buy |
| Upside Potential: | 33% |
| Summary: | Raise December NIFTY target to 17400 |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | |
Reports On Company: Model Portfolio
| Latest List Of High Dividend Yield Stocks (6th May 2021) By HDFC Sec | |
| Company: | Model Portfolio |
| Brokerage: | HDFC Sec |
| Date of report: | March 16, 2021 |
| Type of Report: | Model Portfolio |
| Recommendation: | Buy |
| Upside Potential: | 14.6% |
| Summary: | table of companies (CNX 500 stocks) that offer dividend yield of 3.00% and above |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | |
Reports On Company: Model Portfolio
| 21 Stocks for Medium/Long Term SIP: HDFC Sec Research Report | |
| Company: | Model Portfolio |
| Brokerage: | HDFC Sec |
| Date of report: | May 7, 2021 |
| Type of Report: | Model Portfolio |
| Recommendation: | Buy |
| Upside Potential: | 100% |
| Summary: | Staggered buying is recommended to benefit from any future falls and have better margin of safety |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | |
Reports On Company: Model Portfolio
| Time To Be Cautious About Some Smallcap And Midcap Stocks: HDFC Sec Report | |
| Company: | Model Portfolio |
| Brokerage: | HDFC Sec |
| Date of report: | April 29, 2021 |
| Type of Report: | Sector Report |
| Recommendation: | Sell |
| Upside Potential: | 90% |
| Summary: | Smallcap and midcap space..is it time to be more selective? |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | |
Reports On Company: Model Portfolio
| Covid 2.0: Investment Ideas | |
| Company: | Model Portfolio |
| Brokerage: | Axis Securities |
| Date of report: | April 23, 2021 |
| Type of Report: | Model Portfolio |
| Recommendation: | Buy |
| Upside Potential: | 39% |
| Summary: | Reduce NIFTY50 target to 16100 but remain cautiously optimistic |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | |
Reports On Company: Model Portfolio
| Best Cement Stocks To Buy Now: HDFC Sec Research Report | |
| Company: | HDFC Sec, Model Portfolio |
| Brokerage: | HDFC Sec |
| Date of report: | April 13, 2021 |
| Type of Report: | Sector Report |
| Recommendation: | Buy |
| Upside Potential: | 100% |
| Summary: | long-term trends are likely to drive the cement industry over the next few years |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | |
Reports On Company: Model Portfolio
| Top 5 Pharma Stocks To Buy Now: Edelweiss Research Report | |
| Company: | Model Portfolio, Sun Pharma |
| Brokerage: | Edelweiss |
| Date of report: | April 12, 2021 |
| Type of Report: | Model Portfolio |
| Recommendation: | Buy |
| Upside Potential: | 22% |
| Summary: | SUN PHARMA entering into an earnings upgrade cycle |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | |
Reports On Company: Model Portfolio
| Axis Top Picks for April 2021 | |
| Company: | Model Portfolio |
| Brokerage: | Axis Securities |
| Date of report: | April 1, 2021 |
| Type of Report: | Model Portfolio |
| Recommendation: | Buy |
| Upside Potential: | 100% |
| Summary: | New Fiscal; New Hope! |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | |
Reports On Company: Model Portfolio
| Best 5 Specialty Ingredients Stocks To Buy Now: Research Report By Nirmal Bang | |
| Company: | Advanced Enzymes Technologies, Camlin Fine Sciences, Fine Organic, Galaxy Surfactants, Model Portfolio, Rossari Biotech |
| Brokerage: | Nirmal Bang |
| Date of report: | April 1, 2021 |
| Type of Report: | Initiating Coverage |
| Recommendation: | Buy |
| Upside Potential: | 29% |
| Summary: | Indian companies are leveraging this opportunity whereby they deal with some global companies for sourcing ingredients and subsequently provide value-added solutions to clients based on their requirements |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | |